stockrowBraveheart Bio, Inc. (BRVE) vs Generate Biomedicines, Inc. (GENB)
- Braveheart Bio, Inc. BRVE 18.60 +6.77%
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
Braveheart Bio, Inc. and Generate Biomedicines, Inc. are both Biotechnology companies. Braveheart Bio, Inc. and Generate Biomedicines, Inc. are of similar size ($1.6B and $1.6B). Braveheart Bio, Inc. has the higher net margin (0.00% vs −781.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Braveheart Bio, Inc. leads on 7 and Generate Biomedicines, Inc. on 1.
Valuation
Profitability
| Metric | BRVE | GENB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 68.51% |
| Operating margin | 0.00% | (751.19%) | 0.00% |
| Net margin | 0.00% | (781.10%) | 0.00% |
| Free cash flow margin | 0.00% | (1,692.17%) | 0.00% |
| Return on equity | 0.00% | 0.00% | (51.96%) |
| Return on assets | 0.00% | (90.35%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack